Regatieri, Caio V <br/><br/>
Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated glycosaminoglycans.  [electronic resource] 

 -  Investigative ophthalmology & visual science  Nov 2009 
 - 5487-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-5783 
<br/><br/><label>Standard No.: </label>10.1167/iovs.08-3171  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Choroid--metabolism<br/>Choroidal Neovascularization--etiology<br/>Disease Models, Animal<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Fluorescein Angiography<br/>Fluorescent Antibody Technique, Indirect<br/>Glycosaminoglycans--metabolism<br/>Humans<br/>Infliximab<br/>Injections<br/>Laser Coagulation--adverse effects<br/>Rats<br/>Rats, Zucker<br/>Retina--metabolism<br/>Retinal Pigment Epithelium<br/>Syndecan-4--metabolism<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Vitreous Body<br/>von Willebrand Factor--metabolism